Special Issue: Antifungal Agents Recently Approved or under Development

Espinel-Ingroff, Ana; Dannaoui, Éric

doi:10.3390/jof7030239

Cited by 2 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Difficulties in Evaluating Mucormycosis: Because it is an uncommon illness with a variety of hosts and locations of infection, as well as a plethora of offending Mucorales, there are fewer data available for therapy. As a result, no prospective, randomized clinical trials exist (Prakash & Chakrabarti,2021), (Sipsas et al, 2018), (Alekseyev et al, 2021), (Espinel Ingroff & Dannaoui, 2021), (Sipsas et al, n.d.) Regular Treatment of Mucormycosis:…”

Section: Treatment Modalities Usedmentioning

confidence: 99%

Tangential role of therapeutics in COVID-19 induced Mucormycosis: A Review

Raj

Bhati

2022

EAJMR

View full text Add to dashboard Cite

Due to restricted treatment alternatives that were excessively expensive, people resorted to an integrated strategy with other relevant professions to reduce the burden on a single therapy. Objective: To estimate our ability to live with the limited disease load while reviewing the likely influence of holistic science on sustaining health dimensions. Method: PubMed, Google Scholar, and other embedded websites chose 205 Mucormycosis papers for examination, and 69 publications were chosen from diverse sources for the study. The study concentrated on clinical symptoms, risk factors for mortality, and future integrative therapeutic options, with a particular emphasis on Indian demographic data. Data were extracted from the study about India and Indian peoples based on descriptions and facts. Conclusion: Integrative preventive strategies and therapeutic approaches can reduce the burden on one drug and can prove cost-effective with better.

show abstract

Section: Treatment Modalities Usedmentioning

confidence: 99%

Tangential role of therapeutics in COVID-19 induced Mucormycosis: A Review

Raj

Bhati

2022

EAJMR

View full text Add to dashboard Cite

show abstract

The contribution of fungi to the global economy

et al. 2023

View full text Add to dashboard Cite

Fungi provide ecological and environmental services to humans, as well as health and nutritional benefits, and are vital to numerous industries. Fermented food and beverage products from fungi are circulating in the market, generating billions of USD. However, the highest potential monetary value of fungi is their role in blue carbon trading because of their ability to sequester large amounts of carbon in the soil. There are no conclusive estimates available on the global monetary value of fungi, primarily because there are limited data for extrapolation. This study outlines the contribution of fungi to the global economy and provides a first attempt at quantifying the global monetary value of fungi. Our estimate of USD 54.57 trillion provides a starting point that can be analysed and improved, highlighting the significance of fungi and providing an appreciation of their value. This paper identifies the different economically valuable products and services provided by fungi. By giving a monetary value to all important fungal products, services, and industrial applications underscores their significance in biodiversity and conservation. Furthermore, if the value of fungi is well established, they will be considered in future policies for effective ecosystem management.

show abstract

Special Issue: Antifungal Agents Recently Approved or under Development

Abstract: Many thanks to all contributors to the Special Issue on “Antifungal Agents Recently Approved or Under Development (Current Knowledge and Future Perspectives)” [...]

Cited by 2 publications

References 11 publications

Tangential role of therapeutics in COVID-19 induced Mucormycosis: A Review

Tangential role of therapeutics in COVID-19 induced Mucormycosis: A Review

The contribution of fungi to the global economy

Contact Info

Product

Resources

About